64Cu-PSMA-I&T
Drug
Curium US LLC
Total Payments
$13,578
Transactions
11
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $13,578 | 11 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,578 | 11 | 100.0% |
Top Doctors Receiving Payments for 64Cu-PSMA-I&T
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Health Service | Washington, DC | $2,713 | 2 |
| , M.D | Medical Oncology | Baltimore, MD | $2,713 | 2 |
| , MD | Medical Oncology | New York, NY | $2,713 | 2 |
| , M.D | Nuclear Radiology | San Francisco, CA | $2,713 | 2 |
| , MD | Nuclear Imaging & Therapy | Los Angeles, CA | $2,713 | 2 |
| , MD | Nuclear Medicine | New York, NY | $12.99 | 1 |
Ad
Manufacturing Companies
- Curium US LLC $13,578
Product Information
- Type Drug
- Total Payments $13,578
- Total Doctors 6
- Transactions 11
About 64Cu-PSMA-I&T
64Cu-PSMA-I&T is a drug associated with $13,578 in payments to 6 healthcare providers, recorded across 11 transactions in the CMS Open Payments database. The primary manufacturer is Curium US LLC.
Payment data is available from 2020 to 2020. In 2020, $13,578 was paid across 11 transactions to 6 doctors.
The most common payment nature for 64Cu-PSMA-I&T is "Consulting Fee" ($13,578, 100.0% of total).